{"id":"https://openalex.org/W2139659138","doi":"https://doi.org/10.1517/13543784.2012.658915","title":"Phosphodiesterase inhibitors in inflammatory bowel disease","display_name":"Phosphodiesterase inhibitors in inflammatory bowel disease","alternate_titles":[],"publication_year":2012,"publication_date":"2012-02-06","ids":{"openalex":"https://openalex.org/W2139659138","doi":"https://doi.org/10.1517/13543784.2012.658915","mag":"2139659138","pmid":"https://pubmed.ncbi.nlm.nih.gov/22303952"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.2012.658915","doi":"https://doi.org/10.1517/13543784.2012.658915","is_oa":true,"landing_page_url":"https://doi.org/10.1517/13543784.2012.658915","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1517/13543784.2012.658915?needAccess=true&role=button","source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139659138"],"child_works_count":0,"type":"editorial","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1517/13543784.2012.658915?needAccess=true&role=button","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016175285","display_name":"Pooneh Salari","orcid":"https://orcid.org/0000-0001-5595-0087","observed_orcids":["https://orcid.org/0000-0001-5595-0087"]},"institutions":[{"id":"https://openalex.org/I70640408","display_name":"Tehran University of Medical Sciences","ror":"https://ror.org/01c4pz451","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Pooneh Salari","raw_affiliation_strings":["Tehran University of Medical Sciences, Medical Ethics and History of Medicine Research Center, Tehran, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tehran University of Medical Sciences, Medical Ethics and History of Medicine Research Center, Tehran, Iran","institution_ids":["https://openalex.org/I70640408"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068915111","display_name":"Mohammad Reza Abdollahi","orcid":"https://orcid.org/0000-0003-0123-1209","observed_orcids":["https://orcid.org/0000-0003-0123-1209","https://orcid.org/0009-0001-0204-3093"]},"institutions":[{"id":"https://openalex.org/I4403928236","display_name":"Endocrine and Metabolism Research Center","ror":"https://ror.org/034qe8j39","country_code":"IR","type":"facility","lineage":["https://openalex.org/I4403928185","https://openalex.org/I4403928236","https://openalex.org/I4403928377","https://openalex.org/I70640408"]},{"id":"https://openalex.org/I4403928403","display_name":"Pharmaceutical Sciences Research Center","ror":"https://ror.org/02m2rj159","country_code":"IR","type":"facility","lineage":["https://openalex.org/I4403928403","https://openalex.org/I70640408"]},{"id":"https://openalex.org/I70640408","display_name":"Tehran University of Medical Sciences","ror":"https://ror.org/01c4pz451","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Mohammad Abdollahi","raw_affiliation_strings":["Tehran University of Medical Sciences, Faculty of Pharmacy, and Pharmaceutical Sciences Research Center, and Endocrinology and Metabolism Research Institute, Tehran 1417614411, Iran mohammad@tums.ac.ir"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tehran University of Medical Sciences, Faculty of Pharmacy, and Pharmaceutical Sciences Research Center, and Endocrinology and Metabolism Research Institute, Tehran 1417614411, Iran mohammad@tums.ac.ir","institution_ids":["https://openalex.org/I4403928236","https://openalex.org/I4403928403","https://openalex.org/I70640408"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":40,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"3","first_page":"261","last_page":"264"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.8422999978065491,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.8422999978065491,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.15230000019073486,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phosphodiesterase-inhibitors","display_name":"phosphodiesterase inhibitors","score":0.9829999804496765},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.9570000171661377},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":0.9480000138282776},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":1.0},{"id":"https://openalex.org/keywords/phosphodiesterase-4-inhibitors","display_name":"phosphodiesterase-4 inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/phosphodiesterase-5-inhibitors","display_name":"phosphodiesterase-5 inhibitors","score":0.9490000009536743},{"id":"https://openalex.org/keywords/roflumilast","display_name":"roflumilast","score":0.8519999980926514},{"id":"https://openalex.org/keywords/sildenafil","display_name":"sildenafil","score":0.7319999933242798},{"id":"https://openalex.org/keywords/rolipram","display_name":"rolipram","score":0.746999979019165},{"id":"https://openalex.org/keywords/experimental-colitis","display_name":"experimental colitis","score":0.8050000071525574},{"id":"https://openalex.org/keywords/anti-inflammatory-agents","display_name":"anti-inflammatory agents","score":0.7120000123977661},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.656000018119812},{"id":"https://openalex.org/keywords/prooxidant-antioxidant-balance","display_name":"prooxidant-antioxidant balance","score":0.9160000085830688}],"concepts":[{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.7854599952697754},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.755401611328125},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7366951704025269},{"id":"https://openalex.org/C2778926808","wikidata":"https://www.wikidata.org/wiki/Q693482","display_name":"Roflumilast","level":3,"score":0.7294728755950928},{"id":"https://openalex.org/C2776958096","wikidata":"https://www.wikidata.org/wiki/Q410285","display_name":"Rolipram","level":4,"score":0.7142605185508728},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.6755896806716919},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.5498946309089661},{"id":"https://openalex.org/C2775862500","wikidata":"https://www.wikidata.org/wiki/Q2453464","display_name":"Colitis","level":2,"score":0.53882896900177},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4918384552001953},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4708646833896637},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.46266818046569824},{"id":"https://openalex.org/C2779280984","wikidata":"https://www.wikidata.org/wiki/Q1472","display_name":"Crohn's disease","level":3,"score":0.4516623616218567},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41089802980422974},{"id":"https://openalex.org/C62826618","wikidata":"https://www.wikidata.org/wiki/Q424304","display_name":"Phosphodiesterase","level":3,"score":0.3391304910182953},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.2941383719444275},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.23459786176681519},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22878456115722656},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1097516119480133},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1087627112865448},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.05666106939315796},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000975","descriptor_name":"Antioxidants","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003093","descriptor_name":"Colitis, Ulcerative","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003093","descriptor_name":"Colitis, Ulcerative","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D003093","descriptor_name":"Colitis, Ulcerative","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003424","descriptor_name":"Crohn Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003424","descriptor_name":"Crohn Disease","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D003424","descriptor_name":"Crohn Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010726","descriptor_name":"Phosphodiesterase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010726","descriptor_name":"Phosphodiesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016877","descriptor_name":"Oxidants","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543784.2012.658915","doi":"https://doi.org/10.1517/13543784.2012.658915","is_oa":true,"landing_page_url":"https://doi.org/10.1517/13543784.2012.658915","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1517/13543784.2012.658915?needAccess=true&role=button","source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:22303952","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22303952","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Editorial"}],"best_oa_location":{"id":"doi:10.1517/13543784.2012.658915","doi":"https://doi.org/10.1517/13543784.2012.658915","is_oa":true,"landing_page_url":"https://doi.org/10.1517/13543784.2012.658915","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1517/13543784.2012.658915?needAccess=true&role=button","source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139659138.pdf","grobid_xml":"https://content.openalex.org/works/W2139659138.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1500536957","https://openalex.org/W1975780666","https://openalex.org/W1979516737","https://openalex.org/W1992243371","https://openalex.org/W1994135000","https://openalex.org/W1998235681","https://openalex.org/W2001250955","https://openalex.org/W2012755885","https://openalex.org/W2016996348","https://openalex.org/W2019819611","https://openalex.org/W2024594044","https://openalex.org/W2047229476","https://openalex.org/W2058427553","https://openalex.org/W2081181661"],"related_works":["https://openalex.org/W4200625666","https://openalex.org/W1975780666","https://openalex.org/W1994135000","https://openalex.org/W2085087397","https://openalex.org/W2625049249","https://openalex.org/W2170395778","https://openalex.org/W3011456577","https://openalex.org/W3134417364","https://openalex.org/W4401198816","https://openalex.org/W2161734866"],"abstract_inverted_index":{"Inflammatory":[0],"bowel":[1],"disease":[2,10,20],"(IBD)":[3],"is":[4,116,166,193],"fundamentally":[5],"a":[6,23],"relapsing":[7],"and":[8,34,69,103,113,127,159,173,191],"remitting":[9],"appearing":[11],"in":[12,43,75,87,93,111,134,145,163],"forms":[13],"of":[14,39,91,96,101,170,182,189],"ulcerative":[15],"colitis":[16,147],"(UC)":[17],"or":[18],"Crohn's":[19],"(CD)":[21],"with":[22,99,125],"non-well-known":[24],"etiology.":[25],"With":[26],"the":[27,37,44,55,94,118,139,153,179],"hope":[28],"to":[29,35,132],"prevent":[30],"adverse":[31],"drug":[32],"events":[33],"increase":[36],"efficacy":[38],"therapies":[40],"for":[41],"IBD,":[42],"recent":[45],"years,":[46],"other":[47,108],"than":[48],"new":[49],"monoclonal":[50],"antibodies":[51],"such":[52],"as":[53,138,178],"infliximab,":[54],"novel":[56],"phosphodiesterase":[57],"inhibitors":[58,169],"(PDEIs)":[59],"have":[60,71,83,121],"been":[61,85],"introduced.":[62],"Among":[63],"PDE4Is,":[64],"rolipram,":[65],"OPC-6535,":[66],"mesopram,":[67],"roflumilast":[68],"tetomilast":[70],"shown":[72,122,142],"beneficial":[73],"effects":[74,144],"experimental":[76,135,146],"colitis.":[77],"Unfortunately":[78],"until":[79],"now,":[80],"human":[81],"studies":[82],"not":[84],"successful":[86],"showing":[88],"significant":[89],"superiority":[90],"PDE4Is":[92,102,126,190],"treatment":[95],"IBD.":[97],"Parallel":[98],"discovery":[100],"their":[104,160],"anti-inflammatory":[105,187],"properties,":[106],"inhibiting":[107],"PDE":[109,157],"isoenzymes":[110],"immune":[112],"proinflammatory":[114],"cells":[115],"on":[117],"way.":[119],"PDE7Is":[120,192],"synergistic":[123,186],"effect":[124,188],"they":[128],"may":[129],"act":[130],"similar":[131],"PDE3Is":[133],"settings.":[136],"Sildenafil":[137],"PDE5I":[140],"has":[141],"good":[143,176],"by":[148],"balancing":[149],"oxidant-antioxidant":[150],"status.":[151],"Although":[152],"present":[154],"data":[155],"about":[156],"superfamily":[158],"specific":[161],"roles":[162],"gastrointestinal":[164],"tract":[165],"limited":[167],"but":[168],"PDE4,":[171],"PDE5":[172],"PDE7":[174],"seem":[175],"candidates":[177],"next":[180],"generation":[181],"effective":[183],"drugs.":[184],"The":[185],"also":[194],"important.":[195]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139659138","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
